Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01364844
What this trial is testing

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Solid TumorColorectal CancerEndometrial Cancer
Daiichi Sankyo 42
Early research (Phase 1)Study completedNCT02894944
What this trial is testing

Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Seoul National University Hospital 9
Testing effectiveness (Phase 2)Ended earlyNCT01562899
What this trial is testing

MEK162 and AMG 479 in Patients With Selected Solid Tumors

Who this might be right for
Metastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma
Pfizer 77
Testing effectiveness (Phase 2)Ended earlyNCT02609984
What this trial is testing

Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002)

Who this might be right for
SarcomaMyxoid/Round Cell LiposarcomaSynovial Sarcoma+4 more
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 89
Early research (Phase 1)Study completedNCT00291447
What this trial is testing

111In-ch806 in Patients With Advanced Tumours Expressing the 806 Antigen

Who this might be right for
Neoplasms
Ludwig Institute for Cancer Research 8
Testing effectiveness (Phase 2)Study completedNCT06395753
What this trial is testing

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Debiopharm International SA 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07826195
What this trial is testing

A Phase IIa Study Evaluating Injectable ALK-N001 in Patients With Advanced Gastrointestinal Tumors

Who this might be right for
Advanced Gastrointestinal Tumors
Zhejiang Anglikang Pharmaceutical Co., Ltd. 174
Testing effectiveness (Phase 2)Study completedNCT03463681
What this trial is testing

CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 49
Early research (Phase 1)Looking for participantsNCT07139067
What this trial is testing

Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor Cancer
Peking University 10
Not applicableLooking for participantsNCT06643000
What this trial is testing

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Who this might be right for
Non-small Cell Lung CancerLeptomeningeal MetastasisEGFR Gene Mutation
Henan Cancer Hospital 60
Not applicableStudy completedNCT02172690
What this trial is testing

Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese Patients

Who this might be right for
Gastric CancerPeritoneal Metastases
Peking University 452
Early research (Phase 1)Looking for participantsNCT07247110
What this trial is testing

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 250
Post-approval studies (Phase 4)UnknownNCT06169410
What this trial is testing

Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Yang Jianjun, PhD 140
Early research (Phase 1)Study completedNCT02101580
What this trial is testing

Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Polaris Group 21
Not applicableStudy completedNCT05592873
What this trial is testing

Oncological Impact of Lateral Nodes in Rectal Cancer

Who this might be right for
Colorectal Adenocarcinoma
Niguarda Hospital 317
Early research (Phase 1)Study completedNCT04672369
What this trial is testing

Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC

Who this might be right for
Advanced Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04069273
What this trial is testing

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal CancerAdenocarcinoma
Harry H Yoon 58
Early research (Phase 1)UnknownNCT03002805
What this trial is testing

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

Who this might be right for
Sarcoma
CBA Research 46
Testing effectiveness (Phase 2)Looking for participantsNCT06039631
What this trial is testing

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

Who this might be right for
Larynx CancerHypopharyngeal Cancer
Fudan University 82
Not applicableLooking for participantsNCT06904131
What this trial is testing

A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors

Who this might be right for
Gynecological Solid Tumors
Obstetrics & Gynecology Hospital of Fudan University 20
Next Page